Compare OCUL & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCUL | NEOG |
|---|---|---|
| Founded | 2006 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.9B |
| IPO Year | 2014 | 1995 |
| Metric | OCUL | NEOG |
|---|---|---|
| Price | $8.12 | $9.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $22.90 | $10.67 |
| AVG Volume (30 Days) | ★ 5.2M | 2.3M |
| Earning Date | 05-04-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.09 |
| Revenue | $1,990,000.00 | ★ $894,661,000.00 |
| Revenue This Year | $9.35 | N/A |
| Revenue Next Year | $92.88 | $1.67 |
| P/E Ratio | ★ N/A | $93.11 |
| Revenue Growth | ★ 3.48 | N/A |
| 52 Week Low | $6.23 | $3.87 |
| 52 Week High | $16.44 | $11.43 |
| Indicator | OCUL | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 38.25 | 40.47 |
| Support Level | $6.23 | $8.93 |
| Resistance Level | $12.38 | $10.30 |
| Average True Range (ATR) | 0.44 | 0.50 |
| MACD | -0.14 | -0.14 |
| Stochastic Oscillator | 10.86 | 31.40 |
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.